Health

(Reuters) - U.S. Department of Agriculture experts knew about sanitary problems at one of the two Iowa farms at the center of a massive nationwide egg recall, but did not notify health authorities, the Wall Street Journal reported.

WASHINGTON (Reuters) - Reforms will slightly accelerate the rise in healthcare spending, according to a survey released on Thursday, handing Republicans more ammunition as they attack the Obama administration's legislative victory.

NEW YORK (Reuters) - All patients in a study of a Johnson & Johnson drug for advanced prostate cancer will be offered the medicine after an independent monitoring committee found it demonstrated an improvement in patient survival.

LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.

LONDON (Reuters) - Men who have a certain genetic variations that put them at higher risk of prostate cancer may benefit from regular screening for the disease, a study by British scientists found Friday.

WASHINGTON (Reuters) - A U.S. appeals court granted on Thursday an Obama administration request to temporarily lift a judge's ban on federal funding of research involving human embryonic stem cells.

WASHINGTON (Reuters) - The risks of a potential new diet pill and a 13-year-old weight-loss medicine face U.S. scrutiny next week as medical experts consider if the drugs' benefits outweigh possible side effects.

CHICAGO (Reuters) - The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.

NEW YORK (Reuters Health) - Exposure to extremely low-frequency magnetic fields (ELF-MFs)--emitted by anything from power lines to appliances or improperly grounded wiring--is not likely to increase children's risk of developing brain tumors, the authors of a new analysis conclude.

NEW YORK (Reuters) - New warnings of a potentially fatal skin disease will be added to labels for imaging drugs sold by Bayer, Covidien and GE Healthcare cautioning against their use by patients with kidney disease, the U.S. Food and Drug Administration said on Thursday.

WASHINGTON (Reuters) - U.S. reforms will slightly accelerate the rise in healthcare spending, according to a survey released on Thursday, handing Republicans more ammunition as they attack the Obama administration's legislative victory.

NEW YORK (Reuters Health) - With the advent of folic-acid supplementation of certain foods, few Canadians are now getting too little of the B vitamin, a new study estimates -- in findings that question the need for children and men to get additional folic acid from vitamins.

LONDON (Reuters) - Transmission of the AIDS virus seems to be "out of control" among gay men in France despite an overall fall in the number of new HIV cases in the country, according to a study published on Thursday.

WASHINGTON (Reuters) - Medicare patients with more doctors to choose from do not necessarily get more or better care, researchers reported on Thursday in an analysis demonstrating how complicated U.S. healthcare reform will be.

WASHINGTON (Reuters) - New U.S. reforms are poised to dramatically shift the nation's healthcare spending, not only curbing Medicare costs but also pumping more money toward the private sector as roughly 32 million people gain coverage.

WASHINGTON (Reuters) - Researchers have identified two new genetic mutations that cause a significant number of the hardest-to-treat kinds of ovarian cancer, and say they point to a new "on-off" switch for tumors.

NEW DELHI (Reuters) - Thousands of AIDS patients in India are not receiving treatment on time, underscoring huge challenges the country faces as it combats the disease, the Global Fund To Fight AIDS, Tuberculosis and Malaria said on Thursday.

CHICAGO (Reuters) - Johnson & Johnson has pledged grant money, drugs and research funding for new HIV and tuberculosis medications as part of a five-year, private sector effort to improve the health up to 120 million women and children in developing nations each year.

NEW YORK (Reuters Health) - Taking a multivitamin is unlikely to help colon cancer patients in battling the disease, suggests a new study.

WASHINGTON (Reuters) - Younger chief executives with high testosterone levels may be more likely to try a hostile takeover -- and to get burned in the attempt, Canadian researchers said on Wednesday.